InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
4
T+90 胜率
0%
T+90 平均收益
-47.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Hanly Ann M., 首席技术官. Insider active across 1 company, notably Vir Biotechnology, Inc.. Cumulatively, 8 disclosures have been logged. Split: 1 buy · 4 sells. Total volume traded: €270k. Activity tracked since 29 November 2021. The latest transaction was filed on 24 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hanly Ann M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
14,168 股@ US$9.453447.2% 占其流量Common StockSEC:0001628280-25-007706:0
2,711 股@ US$10.0529.4% 占其流量Common StockSEC:0001628280-24-014468:0
32,500 股0Common StockSEC:0001628280-24-006985:0
2,627 股@ US$22.7720.3% 占其流量Common StockSEC:0001209191-23-021853:0
37,500 股0Common StockSEC:0001209191-23-013006:0
2,627 股@ US$26.237322.8% 占其流量Common StockSEC:0001209191-22-021728:0
53,500 股0Common StockSEC:0001209191-22-012955:0
11.52 股@ US$43.390.2% 占其流量Common StockSEC:0001209191-21-067380:0
标准退出：2022年2月27日 (T+90)
8 条申报中的 8 条
About Hanly Ann M.
HANLY ANN M. is Directeur Technique and EVP & Chief Technology Officer at Vir Biotechnology, Inc. Across 8 total filings, the 8 sampled filings run from 2021-12-01 to 2025-02-25, with buy volume of EUR 443 and sell volume of EUR 269850, and the modal transaction nature is Sale.
